Funder: National Institutes of Health
Due Dates: May 9, 2025 (AIDS) | September 9, 2025 (AIDS) | January 9, 2026 (AIDS)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years. Typical R01 NIH policies apply.
Summary: Supports innovative research to optimize HIV prevention and care continuum outcomes, including behavioral, social science, intervention development, and efficacy/effectiveness trials aligned with NIMH AIDS Research priorities.
Key Information: Clinical trials are optional; foreign and domestic organizations are eligible; applications must address HIV prevention or treatment outcomes as primary outcomes.